A Message To: Tamarac Taxpayers
TAMARAC, Fla., May 21, 2024 /PRNewswire/ — Coastal Waste & Recycling Will Save Tamarac Taxpayers Millions of Dollars on Their Garbage, Recycling, and Bulk Collection Services.
Coastal Waste & Recycling submitted the lowest price to the City of Tamarac for the City’s solid waste, recycling, and bulk collection services. By choosing Coastal, the City will save more than $2.6 million dollars over the next 7 years.
In addition to being the lowest cost provider, Coastal Waste & Recycling scored the highest amongst all other bidders during the evaluation process. If selected by the City Commission, Coastal Waste & Recycling will use all brand new trucks and brand new commercial and multi-family dumpsters throughout Tamarac.
The Commission is meeting this Wednesday, May 22nd at 9:30 am to vote on which company will serve the City. Please call or e-mail the Mayor and Commissioners to voice your support for Coastal Waste & Recycling and save City taxpayers $2.6 million dollars.
View original content to download multimedia:https://www.prnewswire.com/news-releases/a-message-to-tamarac-taxpayers-302151861.html
SOURCE Coastal Waste & Recycling, Inc.
You may also like
Experience Abu Dhabi Team Up with Manchester City for “Penalty Itinerary” Challenge in New York
Manchester City stars Haaland, Grealish and Bobb wowed fans at an interactive activation during US S
Liberty Unveils Women’s Day Brand Video ‘Girls Breaking Free’: Celebrates Courage, Pride, and Empowerment
MUMBAI, India, March 12, 2024 /PRNewswire/ — Liberty General Insurance launches its Women̵
![DifGen Pharmaceuticals Acquires the Operating and Manufacturing Assets of an FDA-Registered Finished Dosage Manufacturing Facility in Florida, Enhancing its Manufacturing Footprint in the United States With the Addition of Manufacturing Capabilities in Sterile/ Non-Sterile Inhalation, Ophthalmic, [Otic] and Unit Dose Formulations](https://brewuptrend.com/wp-content/uploads/2024/03/favicon-vuQtJA.png "DifGen Pharmaceuticals Acquires the Operating and Manufacturing Assets of an FDA-Registered Finished Dosage Manufacturing Facility in Florida, Enhancing its Manufacturing Footprint in the United States With the Addition of Manufacturing Capabilities in Sterile/ Non-Sterile Inhalation, Ophthalmic, [Otic] and Unit Dose Formulations"){kind=small}
DifGen Pharmaceuticals Acquires the Operating and Manufacturing Assets of an FDA-Registered Finished Dosage Manufacturing Facility in Florida, Enhancing its Manufacturing Footprint in the United States With the Addition of Manufacturing Capabilities in Sterile/ Non-Sterile Inhalation, Ophthalmic, [Otic] and Unit Dose Formulations
MIRAMAR, Fla., March 18, 2024 /PRNewswire/ — DifGen Pharmaceuticals LLC (“DifGen”)
